Pmv Pharmaceuticals Correlations
PMVP Stock | USD 1.43 0.02 1.42% |
The current 90-days correlation between Pmv Pharmaceuticals and MediciNova is 0.32 (i.e., Weak diversification). The correlation of Pmv Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Pmv Pharmaceuticals Correlation With Market
Modest diversification
The correlation between Pmv Pharmaceuticals and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Pmv |
Moving together with Pmv Stock
0.69 | INZY | Inozyme Pharma | PairCorr |
0.61 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.69 | ADTX | Aditxt Inc | PairCorr |
0.65 | TCRX | Tscan Therapeutics | PairCorr |
0.77 | TERN | Terns Pharmaceuticals | PairCorr |
0.76 | CRNX | Crinetics Pharmaceuticals Earnings Call Tomorrow | PairCorr |
0.85 | CTMX | CytomX Therapeutics | PairCorr |
Moving against Pmv Stock
0.48 | GANX | Gain Therapeutics | PairCorr |
0.44 | OPT | Opthea Earnings Call Tomorrow | PairCorr |
0.4 | LTRN | Lantern Pharma | PairCorr |
0.38 | PHGE | Biomx Inc | PairCorr |
0.35 | CUE | Cue Biopharma | PairCorr |
0.44 | CGTX | Cognition Therapeutics | PairCorr |
0.39 | CPRX | Catalyst Pharmaceuticals Earnings Call Tomorrow | PairCorr |
0.37 | DBVT | DBV Technologies Earnings Call Next Week | PairCorr |
0.7 | OBI | Ondine Biomedical | PairCorr |
0.59 | SSNLF | Samsung Electronics | PairCorr |
0.48 | GPI | Group 1 Automotive | PairCorr |
0.47 | EC | Ecopetrol SA ADR Earnings Call Tomorrow | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pmv Stock performing well and Pmv Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pmv Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ELYM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
MNOV | 2.41 | (0.20) | 0.00 | 1.55 | 0.00 | 6.15 | 24.62 | |||
PHVS | 2.39 | (0.57) | 0.00 | (1.49) | 0.00 | 5.21 | 14.29 | |||
PEPG | 6.29 | (1.27) | 0.00 | 2.22 | 0.00 | 10.24 | 39.96 | |||
ANEB | 4.33 | (0.13) | 0.00 | (0.06) | 0.00 | 7.64 | 40.87 | |||
ACRV | 4.17 | (0.05) | 0.00 | (0.02) | 0.00 | 10.17 | 30.57 | |||
MOLN | 2.62 | (0.07) | 0.00 | 0.15 | 0.00 | 7.84 | 18.67 | |||
MLYS | 3.35 | (0.24) | 0.00 | (0.48) | 0.00 | 7.79 | 26.52 | |||
EWTX | 2.69 | (0.25) | 0.00 | (0.14) | 0.00 | 4.81 | 26.44 | |||
RLYB | 3.10 | (0.70) | 0.00 | (99.87) | 0.00 | 6.98 | 16.58 |
Pmv Pharmaceuticals Corporate Management
Laura Leon | VP Operations | Profile | |
Leila MD | Chief Officer | Profile | |
Winston MBA | COO CFO | Profile | |
Marc MD | Senior Affairs | Profile | |
Tim Smith | Senior Relations | Profile | |
Robert Ticktin | Head Counsel | Profile | |
Deepika PharmD | Chief Officer | Profile |